Loading people...
Amine Marouf is a Principal at Kurma Partners, a European venture capital firm focused on healthcare and biotechnology, based in Paris, France. He originally joined the firm as an Associate in June 2017, where he evaluates early-stage life sciences technologies and sources startup investments for a platform that manages over €700 million in assets alongside its strategic partner, Eurazeo. Prior to his venture capital career, Marouf spent nearly two years leading an independent innovation consultancy from June 2015 to April 2017. He holds a Master of Science degree in Management from ESSEC Business School Paris and a Master of Science degree in Genetics from Université Paris 7 - Denis Diderot. His current professional focus centers on funding seed-stage therapeutics and healthtech ventures by combining his academic expertise in molecular genetics with institutional investment strategies.
Amine Marouf is a key figure at Kurma Partners, a leading European venture capital firm renowned for its deep expertise and significant contributions to the life sciences sector. As a Principal, Amine Marouf plays a pivotal role in the firm's investment strategy, focusing on identifying and nurturing the next generation of innovative healthcare and biotechnology companies. His work is central to Kurma Partners' mission to invest in cutting-edge science and technology that addresses unmet medical needs and improves patient outcomes.
At Kurma Partners, Amine Marouf is deeply involved in the entire investment lifecycle, from initial deal sourcing and rigorous due diligence to portfolio management and strategic support for invested companies. His responsibilities include market analysis, scientific evaluation, and financial modeling to assess the potential of prospective investments. He collaborates closely with entrepreneurs and management teams, leveraging his insights to help guide companies through critical development stages, from preclinical research to clinical trials and commercialization.
Kurma Partners has a strong track record of investing in a diverse range of life sciences sub-sectors, including novel therapeutics, medical devices, diagnostics, and digital health solutions. Amine Marouf's investment focus mirrors this broad scope, with a particular emphasis on areas poised for significant scientific breakthroughs and market disruption. His contributions help ensure that Kurma Partners continues to back companies with robust scientific foundations and strong commercial potential.
While specific details of individual investments led by a Principal like Amine Marouf are often proprietary, his work contributes directly to Kurma Partners' impressive portfolio, which includes numerous companies that have achieved significant milestones in drug development and medical innovation. His career background likely includes a strong foundation in science, medicine, finance, or a combination thereof, providing him with the multidisciplinary perspective essential for success in venture capital within the complex life sciences industry. Professionals in similar roles often bring experience from consulting, investment banking, or direct industry roles within pharmaceutical or biotech companies, equipping them with both strategic and operational insights.
Amine Marouf's dedication to advancing healthcare innovation through strategic venture capital investment underscores Kurma Partners' commitment to fostering a healthier future. His expertise and analytical rigor are invaluable assets in navigating the dynamic landscape of life sciences investment, making him a significant contributor to the firm's continued success and its impact on global health.
Amine Marouf is a Principal at Kurma Partners, a leading European venture capital firm specializing in life sciences investments. He is responsible for identifying, evaluating, and supporting innovative biotech and healthcare companies.
Amine Marouf invests in a wide range of life sciences sectors, including novel therapeutics, medical devices, diagnostics, and digital health solutions. His focus aligns with Kurma Partners' strategy of backing groundbreaking science and technology in healthcare.
Amine Marouf works at Kurma Partners, a prominent European venture capital firm with a strong focus on the life sciences industry.
